Analysis of melanoma cells derived from different areas of the same tumor demonstrated a decreased expression of Sema5A RNA transcript in BRAF mutated melanoma cells derived from the central regions of primary melanoma when compared to the BRAF negative cells derived from peripheral areas, thus indicating that modulation of Sema5A expression could be involved in divergent effects of anticancer agents [15]. This evidence concerns the gene SEMA5A and melanoma.